Volume 17, Issue 2 (March 1989)

    Risk Assessment for Halogenated Solvents


      Format Pages Price  
    PDF (132K) 4 $25   ADD TO CART


    A recent development in the cancer risk area is the advent of biologically based pharmacokinetic and pharmacodynamic models. These models allow for the incorporation of biological and mechanistic data into the risk assessment process. These advances will not only improve the risk assessment process for halogenated solvents but will stimulate and guide basic research in the biological area.

    Author Information:

    Travis, CC
    Office of Risk Analysis, Oak Ridge National Laboratory, Oak Ridge, TN

    Stock #: JTE11099J

    ISSN: 0090-3973

    DOI: 10.1520/JTE11099J

    ASTM International is a member of CrossRef.

    Title Risk Assessment for Halogenated Solvents
    Symposium , 0000-00-00
    Committee E31